Davis Trust Co. continues support of D&E Highlands Scholar Program
Davis & Elkins College President Chris A. Wood, center, accepts a $12,500 check from Davis Trust Co. President and Chief Executive Office Hugh Hitchcock and Executive Vice President Rachel Hayes to support the Highlands Scholar Program.

Davis Trust Co. continues support of D&E Highlands Scholar Program

ELKINS - Davis Trust Co. is continuing its commitment to help local students obtain a high quality liberal arts education by supporting the nationally recognized Davis & Elkins College Highlands…

Continue Reading Davis Trust Co. continues support of D&E Highlands Scholar Program
Just Cuttin’ Up hair salon opens in former Sherry’s Hairport location
Becki Ferguson, manager, and Trent Westfall, owner, of the new Just Cuttin' Up hair salon located at 38 E. Main St.

Just Cuttin’ Up hair salon opens in former Sherry’s Hairport location

BUCKHANNON – A new hair salon welcomed December by hosting a grand opening ceremony today, Saturday Dec. 1. Downtown Buckhannon welcomed Just Cuttin’ Up, a hair salon owned by Trent…

Continue Reading Just Cuttin’ Up hair salon opens in former Sherry’s Hairport location
WVU Cancer Institute studies new treatment for colorectal cancer using novel drug combination
The drug Regorafenib, a commonly used cancer drug, can cause unpleasant side effects. These range from mild nausea to hand and foot pain that makes walking or holding objects difficult. Richard Goldberg, the director of WVU’s Cancer Institute, is researching a treatment regimen that combines Regorafenib with another drug to halt the progression of colorectal cancer while also ameliorating these and other noxious side effects.

WVU Cancer Institute studies new treatment for colorectal cancer using novel drug combination

Once colorectal cancer invades another organ—the liver or lung, for instance—a cancer patient has about a 13 percent chance of living five more years. Richard Goldberg, who directs the West…

Continue Reading WVU Cancer Institute studies new treatment for colorectal cancer using novel drug combination